Armitage James O's Form 4 filing
Cardiff Oncology, Inc. (CRDF) · filed Oct 11, 2022
- Accession no.
- 0001628280-22-026245
- Filed
- Oct 11, 2022
- Trade date
- Sep 16, 2022
- Filing delay
- 25 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $20.3K. It was filed 25 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Armitage James OCIK 0001370087 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2022 | Common Stock | PPurchaseAcquired | +13,000 | $1.56 | +$20,280 | 13,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.